ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $419,000 | +8.0% | 10,344 | -11.7% | 0.01% | -9.1% |
| Q3 2022 | $388,000 | -2.3% | 11,714 | +3.8% | 0.01% | +10.0% |
| Q2 2022 | $397,000 | -27.0% | 11,282 | -45.0% | 0.01% | +900.0% |
| Q2 2019 | $544,000 | +48.2% | 20,515 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $367,000 | +45.6% | 19,993 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $252,000 | -34.4% | 20,301 | +1.3% | 0.00% | 0.0% |
| Q3 2018 | $384,000 | +48.3% | 20,037 | +5.2% | 0.00% | 0.0% |
| Q2 2018 | $259,000 | +219.8% | 19,043 | +69.6% | 0.00% | – |
| Q1 2018 | $81,000 | – | 11,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |